nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Surgical Intervention

Bariatric Surgery
  • Alternative therapy in patients unresponsive to lifestyle changes and pharmacological therapy to reduce weight and metabolic complications as it has long-term stable results
  • It was shown in the surrogate markers that bariatric surgery is effective on NAFLD-associated liver injury and there is also initial evidence for improved necroinflammation and fibrosis
  • It is advised that surgery should be done before the patient becomes cirrhotic
Liver Transplantation
  • Accepted procedure in NASH patients with end-stage liver disease
  • It was found that overall survival after transplantation is approximately identical with patients who received liver transplants for hepatic failure caused by other liver diseases
  • Comorbid conditions limit eligibility for transplantation
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, Yesterday
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
6 days ago
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
4 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.